You are about to go to a non-NYULMC website.
Clinical Addresses
462 FIRST AVENUENEW YORK, NY 10016
Handicap Access: yes
Phone: 212-263-6485
Fax: 212-263-8210
Medical Specialties
Cancer, Medical OncologyMedical Expertise
Breast CancerClinical Responsibilities
Dr. Sylvia Adams specializes in the immunotherapy of solid tumors and the care of patients with breast cancer.Languages
GermanInsurance
Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, LOCAL 1199 PPO, MAGNACARE PPO, NY MEDICAID, NYS EMPIRE PLAN, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIERInsurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.
Board Certification
2003 — Ab Internal Medicine (Medical Oncology)Education
1989-1995 — Friedrich Schiller Universitat, Medical Education1997-2000 — Winthrop University Hospital (Medicine), Residency Training
2000-2003 — NYU Medical Center (Hematology Oncology), Clinical Fellowships
Research Summary
Dr. Adams has expertise in the development and conduct of cancer immunotherapy trials. She received a Master of Science in Clinical Investigation at New York University in 2010 and is the recipient of several awards, including grants from the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI, K23 and R01). She has published several original research articles as well as reviews and book chapters. Dr. Adams also serves as Vice Chair of the NYU-IRB and as Associate Director for Clinical Research at the Bellevue Cancer Center.Research Interests
Breast cancer Immunotherapy of cancer Cancer Vaccines Tumor Immunology Immunotherapy of breast cancer, lung cancer, ovarian cancer and melanomaAll data from NYU Health Sciences Library Faculty Bibliography — -
Five-year Results of Preoperative Paclitaxel with Concurrent Radiation Therapy in Locally Advanced Breast Cancer: Pathological Response Predicts for Survival
Schneider, R. J.; Formenti, S. C.; Chakravarthy, A.; Adams, S.; Spicer, D.; Lymberis, S.; Goldberg, J. D.; Pietenpol, J. A.
2010 OCT 13 ;78(3):S219-S219, International journal of radiation oncology biology physics
—
id: 114016,
year: 2010,
vol: 78,
page: S219,
stat: Journal Article,
Transfection of dendritic cells (DCs) with mRNA encoding IL-12p70 enhances anti-tumor immunity in melanoma patients
Minkis K; Kavanagh D; O'Neill D; Alter G; Sunderji S; Adams S; Walker B; Pavlick AC; Gandhi R; Bhardwaj N
2008 May 20;26(Suppl):?-? #22217, Proceedings (American Society of Clinical Oncology)
—
id: 79466,
year: 2008,
vol: 26,
page: ?,
stat: Journal Article,
Expression of cancer testis (CT) antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM), correlation with prognostic factors and potential role in a melanoma vaccine
Velazquez, EF; Jungbluth, AA; Osman, I; Yancovitz, M; Adams, S; O'Neill, D; Zavilevich, K; Albukh, T; Pavlick, A; Polsky, D; Shapiro, R; Berman, R; Spira, J; Busam, K; Bhardwaj, N
2006 JAN ;19(4):89A-89A, Modern pathology
—
id: 61434,
year: 2006,
vol: 19,
page: 89A,
stat: Journal Article,
Recent advances in dendritic cell biology
Adams, Sylvia; O'Neill, David W; Bhardwaj, Nina
2005 Mar;25(2):87-98, Journal of clinical immunology
—
id: 55977,
year: 2005,
vol: 25,
page: 87,
stat: Journal Article,


